Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nataly Manjarrez-Orduno"'
Autor:
Bradley Garman, Can Jiang, Sherif Daouti, Sanah Kumar, Priyanka Mehta, Miye K. Jacques, Laurence Menard, Nataly Manjarrez-Orduno, Sonia Dolfi, Piali Mukherjee, Sharmila Chamling Rai, Ana Lako, Jennifer D. Koenitzer, Justin M. David
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundImmune cell expression profiling from patient samples is critical for the successful development of immuno-oncology agents and is useful to understand mechanism-of-action, to identify exploratory biomarkers predictive of response, and to gu
Externí odkaz:
https://doaj.org/article/324c0c0207fc4feeb6f9cf0d6a14e5a6
Publikováno v:
Open Biology, Vol 11, Iss 11 (2021)
Radiation has been a pillar of cancer therapy for decades. The effects of radiation on the anti-tumour immune response are variable across studies and have not been explicitly defined in poorly immunogenic tumour types. Here, we employed combination
Externí odkaz:
https://doaj.org/article/96fb3005c03b4be6bd40acd0d2701cc0
Autor:
Justin David, Miye Jacques, Bradley Garman, Laurence Menard, Can Jiang, Sherif Daouti, Priyanka Mehta, Mohan Bolisetty, Nataly Manjarrez Orduno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/cd2b322619b846c38bc2770016928ae2
Publikováno v:
Open Biology, Vol 11, Iss 11 (2021)
Open Biology
Open Biology
Radiation has been a pillar of cancer therapy for decades. The effects of radiation on the anti-tumour immune response are variable across studies and have not been explicitly defined in poorly immunogenic tumour types. Here, we employed combination
Autor:
Bradley Garman, Laurence Menard, Can Jiang, Sherif Daouti, Priyanka Mehta, Miye Jacques, Mohan Bolisetty, Christos Hatzis, Nataly Manjarrez Orduno, Michaela Bowden, Justin David
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Characterization of human immune responses by profiling immune cells from patients is critical for the successful development of immuno-oncology agents and is useful to understand mechanism-of-action, identify pharmacodynamic/response biom
Autor:
Nataly Manjarrez Orduno, Rebecca A. Moss, Jasmine I. Rizzo, Xiao Shao, Charlie Garnett-Benson, Trong Le, Christos Hatzis
Publikováno v:
Clinical Cancer Research. 27:PO-045
Introduction In metastatic melanoma, brain metastases (bmets) are an important cause of death. Standard treatment of asymptomatic bmets consists of systemic therapy with checkpoint inhibitors (CPI) or targeted therapy, whereas local control with surg
Autor:
Paul Fischer, Peter S. Linsley, Bijal Kakrecha, Laurence Menard, Nataly Manjarrez Orduno, Erik Wambre, Steven G. Nadler, Blake J. Rust, Becky Penhallow, Deborah Lee, Maochang Liu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
Checkpoint inhibitors target the inhibitory receptors expressed by tumor-infiltrating T cells in order to reinvigorate an anti-tumor immune response. Therefore, understanding T cell composition and phenotype in human tumors is crucial. We analyzed by
Autor:
Bijal Kakrecha, Paul Fischer, Deborah Lee, Becky Penhallow, Nataly Manjarrez Orduno, Steven G. Nadler, Laurence Menard
Publikováno v:
Cancer Research. 78:4687-4687
Checkpoint inhibitors target the inhibitory receptors expressed by tumor infiltrating T cells in order to reinvigorate an anti-tumor immune response. Therefore, understanding T cell composition and phenotype in human tumors is crucial. We analyzed by
Autor:
Rachel Knevel, Kerstin Klein, Klaartje Somers, Caroline Ospelt, Jeanine J Houwing-Duistermaat, Jessica A B van Nies, Diederik P C de Rooy, Laura de Bock, Fina A S Kurreeman, Joris Schonkeren, Gerrie Stoeken-Rijsbergen, Quinta Helmer, Michael P M van der Linden, Marlena Kern, Nataly Manjarrez-Orduno, Luis Rodriguez-Rodriquez, Piet Stinissen, Tom W J Huizinga, Rene E M Toes, Steffen Gay, Peter K Gregersen, Veerle Somers, Annette H M van der Helm-van Mil
Publikováno v:
Annals of the Rheumatic Diseases, 73(11), 2038-46
Annals of the Rheumatic Diseases, 73(11), 2038-2046
Annals of the Rheumatic Diseases, 73(11), 2038-2046
Background Joint destruction is a hallmark of autoantibody-positive rheumatoid arthritis (RA), though the severity is highly variable between patients. The processes underlying these interindividual differences are incompletely understood. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deaae7b1ef09fd9b3e718d58f6e3b24e
https://hdl.handle.net/1887/118662
https://hdl.handle.net/1887/118662